Velarion Records
Free. Unsubscribe any time.

Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. filed 9 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 12 transactions and 260,056 shares. 9 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Tango Therapeutics, Inc. 12

Adoption dates in Tango Therapeutics, Inc. 1

Results prints in Tango Therapeutics, Inc. 0

Trades before a print in Tango Therapeutics, Inc. 0

Interval to Tango Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Tango Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on October 27, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.